StockData

China SXT Pharmaceuticals, Inc. (SXTC) stock

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.83−0.03 (-1.05%)

Close on Nov 18, 2026Market cap $2.71MP/E –Yield –

China SXT Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$2.35M. The highest annual figure on record is $1.48M in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Mar 31, 2025-$2.35M–
FY2024Mar 31, 2024-$1.94M-340.9%
FY2020Mar 31, 2020$803.41K–
FY2019Mar 31, 2019-$296.63K-120.0%
FY2018Mar 31, 2018$1.48M+1203.4%
FY2017Mar 31, 2017$113.87K–

More China SXT Pharmaceuticals figures

See a number that looks wrong?